CASEY WINELAND: Open Payments
NPI 1780337485 · BELLEFONTE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 22 payments from 9 companies in 2025. Trend: 2023 $684 · 2024 $496 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $92 |
| ABBVIE INC. | 4 | $89 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 1 | $63 |
| Exact Sciences Corporation | 3 | $63 |
| PFIZER INC. | 3 | $62 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: VOQUEZNA, Cologuard Collection Kit, QULIPTA, SHINGRIX, PREVNAR 20, UBRELVY, Ozempic, GEMTESA.
Industry payments across PA — which companies pay providers there.
